Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Siedlce – page 10

140 clinical trials in Siedlce, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Siedlce at a glance
140
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

140 trials in Siedlce

Open in trial search

Type 2 diabetes mellitus+1

Not recruiting

Study on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Survodutide
  • Sponsor:Boehringer Ingelheim Espana S.A.

Obesity

Not recruiting

Study on the Effectiveness of Survodutide for Weight Loss in Adults with Obesity Without Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Survodutide
  • Sponsor:Boehringer Ingelheim International GmbH

Cardiac failure acute

Not recruiting

Study on Empagliflozin and Dapagliflozin for Patients Hospitalized with Acute Heart Failure

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Dapagliflozin
  • Sponsor:Medical University Of Warsaw

Study Comparing XL092 and Atezolizumab with Regorafenib for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Exelixis Inc.

Fallopian tube cancer+2

Not recruiting

Study of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Relacorilant
  • Sponsor:Corcept Therapeutics Inc.

Acne

Not recruiting

Study of N-Acetyl-GED-0507-34-LEVO gel 5% applied daily for treating acne vulgaris

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Busegampar
  • Sponsor:PPM Services S.A.

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Gilead Sciences Inc.

Cardiac failure acute

Not recruiting

Study of dapagliflozin effects in patients hospitalized with acute heart failure

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin Propanediol Monohydrate
  • Sponsor:The Brigham And Women’s Hospital Inc.

Study of TransCon TLR7/8 Agonist, TransCon IL-2 β/γ, and Pembrolizumab for Patients with Advanced Head and Neck Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:ACP-017
  • Sponsor:Ascendis Pharma Oncology Division A/S

Study on Durvalumab with Oleclumab or Monalizumab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB

Gastric cancer

Not recruiting

Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bemarituzumab
  • Sponsor:Amgen Inc.

Endometrial cancer

Not recruiting

Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Siedlce

What the registry says about research in the country

01 Oncology Studies

Extensive research focusing on various cancer types including non-small cell lung cancer, head and neck cancers, and advanced melanoma. Multiple trials evaluating novel immunotherapy combinations and targeted treatments.

  • Lung Cancer Therapies
  • Ovarian Cancer Treatments
  • Immunotherapy Combinations

Studies particularly emphasize innovative approaches for metastatic conditions and treatment-resistant cancers.

02 Metabolic Disorders

Comprehensive research into weight management and metabolic conditions, including trials for obesity and type 2 diabetes. Studies evaluate new therapeutic approaches combined with lifestyle modifications.

  • Weight Management Solutions
  • Diabetes Treatments
  • Metabolic Health Interventions

Focus on developing treatments that work alongside dietary and physical activity changes.

03 Autoimmune Conditions

Innovative trials addressing various autoimmune disorders, including rheumatoid arthritis, psoriatic arthritis, and Sjögren's disease. Research focuses on new biological treatments and disease-modifying therapies.

  • Arthritis Treatments
  • Psoriasis Therapies
  • Autoimmune Disease Management

Emphasis on developing targeted therapies for better disease control and symptom management.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.